DK113583B - Process for the preparation of therapeutically effective 1,2α-methylene-17α-acyloxy-16-methyl-Δ <4,6> -pregnadiene-3,20-diones. - Google Patents

Process for the preparation of therapeutically effective 1,2α-methylene-17α-acyloxy-16-methyl-Δ <4,6> -pregnadiene-3,20-diones.

Info

Publication number
DK113583B
DK113583B DK122566A DK122566A DK113583B DK 113583 B DK113583 B DK 113583B DK 122566 A DK122566 A DK 122566A DK 122566 A DK122566 A DK 122566A DK 113583 B DK113583 B DK 113583B
Authority
DK
Denmark
Prior art keywords
pregnadiene
diones
acyloxy
methylene
methyl
Prior art date
Application number
DK122566A
Other languages
Danish (da)
Inventor
Ag Schering
Original Assignee
Ag Schering
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ag Schering filed Critical Ag Schering
Publication of DK113583B publication Critical patent/DK113583B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
DK122566A 1965-03-09 1966-03-09 Process for the preparation of therapeutically effective 1,2α-methylene-17α-acyloxy-16-methyl-Δ <4,6> -pregnadiene-3,20-diones. DK113583B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DESCH36654A DE1244178B (en) 1965-03-09 1965-03-09 Process for the preparation of alpha, beta-methylene keto steroids

Publications (1)

Publication Number Publication Date
DK113583B true DK113583B (en) 1969-04-08

Family

ID=7433945

Family Applications (1)

Application Number Title Priority Date Filing Date
DK122566A DK113583B (en) 1965-03-09 1966-03-09 Process for the preparation of therapeutically effective 1,2α-methylene-17α-acyloxy-16-methyl-Δ <4,6> -pregnadiene-3,20-diones.

Country Status (5)

Country Link
BR (1) BR6677709D0 (en)
CH (1) CH469690A (en)
DE (1) DE1244178B (en)
DK (1) DK113583B (en)
NL (1) NL155191B (en)

Also Published As

Publication number Publication date
DE1244178B (en) 1967-07-13
NL155191B (en) 1977-12-15
NL6602908A (en) 1966-09-12
CH469690A (en) 1969-03-15
BR6677709D0 (en) 1973-09-06

Similar Documents

Publication Publication Date Title
DK116205B (en) Analogous process for the preparation of 17α-alkanoyloxy-9α-halogen-16β-methyl-11β, 21-dihydroxy-Δ &lt;1,4&gt; -pregnadiene-3,20-diones.
DK128353B (en) Analogous process for the preparation of therapeutically active bis-chromones.
DK120546B (en) Process for the preparation of 2,4-diamino-5-benzylpyrimidines.
DK117631B (en) Process for the preparation of 20-oxopregnan-, 20-oxo-4-pregnene- or 20-oxo-5 (6) -pregnene- (17α, 16α-d) -oxazolines.
DK117957B (en) Process for the preparation of 13β-alkyl-3-oxogona-4,9,11-trienes.
DK119557B (en) Analogous process for the preparation of 17α-benzoyloxy-9α-fluoro-16β-methyl-Δ &lt;1,4&gt; -pregnadiene-11β, 21-diol-3,20-dione.
DK123170B (en) Process for the preparation of therapeutically effective 3-oxo-7α-methyl-Δ &lt;4,9,11&gt; estratrienes.
DK112523B (en) Process for the preparation of 2,3-pyridinediol.
DK115547B (en) Process for the preparation of 17α-acyloxy-16-methyl-9α-fluor-Δ &lt;1,4&gt; -pregnadiene-3,20-diones.
DK122760B (en) Analogous process for the preparation of therapeutically active 4-alkoxy-3,5-dimethoxybenzamides.
DK118557B (en) Process for the preparation of 17α-acyloxy-11β-hydroxy-Δ &lt;4&gt; -pregnant-3,20-diones.
DK118717B (en) Process for the preparation of antidiabetic active benzenesulfonamidopyrimidines.
DK112235B (en) Process for the preparation of therapeutically effective 21-dicyclohexylmethyl carbonates of 21-hydroxy-Δ &lt;4&gt; -pregnen-17α-ol-3,20-diones.
DK114267B (en) Process for the preparation of therapeutically effective 17β-trialkylsiloxy-Δ &lt;4&gt; androstenes or estrenes.
DK115184B (en) Process for the preparation of 6,7-benzomorphans.
DK114962B (en) Process for the preparation of α, α, α &#39;, α&#39;-tetramethyl-xylylene dicarbinols.
DK116594B (en) Process for the preparation of 4,1,5-benzoxadiazocines.
DK116658B (en) Process for the preparation of therapeutically active 7α-methyl-Δ &lt;5&gt; -estrenes.
DK118826B (en) Process for the preparation of 4&#39;-demethyl-epipodophyllotoxin-β-D-glucoside.
DK117420B (en) Analogous process for the preparation of 12-oxygenated-Δ &lt;3&gt; -A-norandrostene-2,17-dione.
DK106329C (en) Process for the preparation of 3,20-dioxo-19-nor-4,9,11-pregnatrien.
DK113583B (en) Process for the preparation of therapeutically effective 1,2α-methylene-17α-acyloxy-16-methyl-Δ &lt;4,6&gt; -pregnadiene-3,20-diones.
DK122452B (en) Analogous process for the preparation of 21-esters of 6α-halogen-16α-methyl-Δ &lt;1,4&gt; -pregnadiene-11β, 21-diol-3,20-diones.
DK109895C (en) Process for the preparation of 1,3-dioxo-2-alkyl-cyclopentanes.
DK121510B (en) Process for the preparation of therapeutically active 7α-methyl-Δ &lt;5 (10)&gt; estreners.